Anal cancer is uncommon in the general population but considerably more common in men who have sex with men, and more common again in people living with HIV. It is caused in the great majority of cases by persistent infection with high-risk strains of human papillomavirus, the same virus responsible for cervical cancer. The UK has no national anal screening programme, but some specialist services offer screening to higher-risk groups.
Who is at higher risk?
People living with HIV, particularly those with a history of a low CD4 count, have the highest rates. Men who have sex with men who are HIV negative have rates well above the general population. Other factors include a history of anal or genital warts, previous HPV-related disease, smoking, and immunosuppression from transplant medication or other causes.
What does screening involve?
Where it is offered, it usually begins with anal cytology, a swab taken from inside the anal canal and examined for abnormal cells, sometimes combined with HPV testing. An abnormal result leads to high-resolution anoscopy, where a clinician examines the anal canal under magnification after applying a solution that makes abnormal areas visible, and takes biopsies of anything suspicious. Some services also use a digital examination as a simple first check, since it can detect masses that cytology would miss.
What happens if changes are found?
Precancerous changes are graded, and high-grade changes can be treated before they become cancer. Treatment options include electrocautery, applied under local anaesthetic, and topical creams. A large trial published in recent years showed that treating high-grade lesions in people living with HIV reduced progression to cancer, which is the evidence base that has driven the expansion of screening programmes internationally.
Why is there no national programme?
Because the balance of benefit and harm at population level is still debated. Anal cytology produces a lot of abnormal results, most of which would never progress, and high-resolution anoscopy is uncomfortable and requires specialist training that is not widely available. UK provision is therefore patchy and concentrated in larger HIV and sexual health services. This is a resource and evidence question rather than a judgement about whether the risk is real.
How do you find out if it is available to you?
Ask your HIV clinic if you have one, since that is where most UK screening sits. If you are HIV negative, ask at your sexual health clinic what is available locally, and be prepared for the answer to be nothing formal. In that situation, knowing the symptoms and acting on them promptly is the realistic alternative.
Which symptoms should prompt an appointment?
Bleeding that persists, a lump you can feel in or around the anus, pain that does not settle, itching that continues for weeks, a change in bowel habit, a feeling of something in the anal canal, or discharge. Every one of these is far more likely to be haemorrhoids, a fissure or an infection, and that is exactly why people wait too long. The relevant point is that symptoms lasting more than a few weeks need examining rather than being attributed to piles indefinitely.
What reduces the risk?
HPV vaccination, which is free through sexual health and HIV services for men who have sex with men up to forty-five and prevents the strains responsible for most anal cancers. Stopping smoking, which has a substantial independent effect. For people living with HIV, sustained treatment with a recovered CD4 count. None of these eliminate risk, but together they change it meaningfully.
The practical position
Get vaccinated if you are eligible, ask your clinic whether screening is available locally, and treat persistent anal symptoms as something to be examined rather than endured.
What does a digital examination involve?
A gloved, lubricated finger inserted for a few seconds to feel for lumps or irregularities. It is brief, not painful, and is the simplest check available. Some clinicians recommend it annually for people at higher risk even where formal screening is not offered, and it is a reasonable thing to ask for at a routine appointment.
Should you examine yourself?
Being familiar with what is normal for you is useful, and noticing a new lump or a change is worth acting on. Self-examination is not a substitute for screening and should not become a source of daily anxiety, but a general awareness helps people present sooner rather than later.